Cargando…

E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody

SARS-CoV2 mutants B.1.1.7, B.1.351, and P.1 contain a key mutation N501Y. B.1.135 and P.1 lineages have another mutation, E484K. Here, we decode the effect of these two mutations on the host receptor, ACE2, and neutralizing antibody (B38) recognition. The N501Y RBD mutant binds to ACE2 with higher a...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chakraborty, Sandipan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641390/ https://www.ncbi.nlm.nih.gov/pubmed/34915409 http://dx.doi.org/10.1016/j.intimp.2021.108424

Ejemplares similares

Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
por: Chakraborty, Sandipan
Publicado: (2021)

Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
por: Chakraborty, Sandipan
Publicado: (2021)

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
por: Wang, Wei Bu, et al.
Publicado: (2021)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

501Y.V2 spike protein resists the neutralizing antibody in atomistic simulations
por: Ngo, Son Tung
Publicado: (2022)

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies
por: Zhu, Xing, et al.
Publicado: (2021)

Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
por: Colson, Philippe, et al.
Publicado: (2022)

The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant
por: Ali, Fedaa, et al.
Publicado: (2021)

In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
por: Çubuk, Hasan, et al.
Publicado: (2022)

A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations
por: Zhao, Yanan, et al.
Publicado: (2021)

The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice
por: Hu, Longbo, et al.
Publicado: (2022)

Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
por: Cheng, Lin, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil
por: Ferrareze, Patrícia Aline Gröhs, et al.
Publicado: (2021)

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022)

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
por: Tian, Fang, et al.
Publicado: (2021)

Decreased interfacial dynamics caused by the N501Y mutation in the SARS-Cov-2 s1 spike:ACE2 complex
por: Ahmed, Wesam S., et al.
Publicado: (2022)

A one-step real-time RT-PCR assay for simultaneous typing of SARS-CoV-2 mutations associated with the E484K and N501Y spike protein amino-acid substitutions
por: Chaintoutis, Serafeim C., et al.
Publicado: (2021)

Orthobunyavirus spike architecture and recognition by neutralizing antibodies
por: Hellert, Jan, et al.
Publicado: (2019)

Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan
por: Hirotsu, Yosuke, et al.
Publicado: (2021)

Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
por: Ahmed, Wesam S., et al.
Publicado: (2022)

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
por: Nonaka, Carolina K. V., et al.
Publicado: (2021)

The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals
por: Uwamino, Yoshifumi, et al.
Publicado: (2022)

Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex
por: Ahmed, Wesam S., et al.
Publicado: (2022)

Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
por: Li, Lili, et al.
Publicado: (2022)

Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern
por: Pondé, R.A.A.
Publicado: (2022)

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2022)

Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q
por: Ahamad, Shahzaib, et al.
Publicado: (2022)

Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study
por: Zhao, Shi, et al.
Publicado: (2021)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Shi, Pei-Yong, et al.
Publicado: (2021)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
por: Lu, Lu, et al.
Publicado: (2021)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
por: Grunau, Brian, et al.
Publicado: (2022)

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
por: Yi, Chunyan, et al.
Publicado: (2020)

Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry
por: Wang, Ke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kubs0v1114f9hfkrn8o37ruhs8